NCT04883450View on ClinicalTrials.gov

PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Pancreatic CancerPancreatic Ductal Adenocarcinoma (PDAC)
Interventions
DIAGNOSTIC_TEST

Magnetic resonance imaging (MRI)

All enrolled participants will undergo magnetic resonance imaging (MRI) at their Baseline and 18-Month follow-up visit

Trial Locations (1)

91101

Kaiser Permanente Southern California, Pasadena

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Kaiser Permanente

OTHER